IDH2 GENE MUTATION
Clinical trials for IDH2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH2 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets Leukemia's weak spot in relapsed patients
Disease control Recruiting nowThis study tests a combination of two drugs, enasidenib and azacitidine, in about 50 adults with a type of leukemia (AML) that has come back or not responded to prior treatment. Participants must have a specific gene mutation (IDH2). The goal is to see if the combo can shrink or …
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New hope for rare blood cancer: targeted pill plus chemo shows promise
Disease control Recruiting nowThis study tests a combination of two drugs—enasidenib (a targeted pill) and azacitidine (a chemotherapy-like drug)—in people with a high-risk blood cancer called myelodysplastic syndrome (MDS) that has a specific IDH2 gene mutation. The goal is to see if the combo is safe and ca…
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC